These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 17196105)

  • 1. The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets.
    Larson BA; Amin AA; Noor AM; Zurovac D; Snow RW
    BMC Public Health; 2006 Dec; 6():314. PubMed ID: 17196105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
    Kangwana BP; Kedenge SV; Noor AM; Alegana VA; Nyandigisi AJ; Pandit J; Fegan GW; Todd JE; Brooker S; Snow RW; Goodman CA
    PLoS Med; 2011 May; 8(5):e1000437. PubMed ID: 21655317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
    Simba D; Kakoko D
    Tanzan J Health Res; 2012 Apr; 14(2):89-95. PubMed ID: 26591729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
    Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP
    Malar J; 2011 Oct; 10():316. PubMed ID: 22029829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya.
    Wasunna B; Okiro EA; Webster J; Todd J; Snow RW; Jones C
    PLoS One; 2015; 10(7):e0130305. PubMed ID: 26135143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops.
    Cohen JM; Sabot O; Sabot K; Gordon M; Gross I; Bishop D; Odhiambo M; Ipuge Y; Ward L; Mwita A; Goodman C
    BMC Health Serv Res; 2010 Jul; 10 Suppl 1(Suppl 1):S6. PubMed ID: 20594372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond antimalarial stock-outs: implications of health provider compliance on out-of-pocket expenditure during care-seeking for fever in South East Tanzania.
    Mikkelsen-Lopez I; Tediosi F; Abdallah G; Njozi M; Amuri B; Khatib R; Manzi F; de Savigny D
    BMC Health Serv Res; 2013 Oct; 13():444. PubMed ID: 24161029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
    Zurovac D; Larson BA; Akhwale W; Snow RW
    Trop Med Int Health; 2006 Aug; 11(8):1185-94. PubMed ID: 16903882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
    Zurovac D; Ndhlovu M; Sipilanyambe N; Chanda P; Hamer DH; Simon JL; Snow RW
    Malar J; 2007 Mar; 6():31. PubMed ID: 17367518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children.
    Moore BR; Davis WA; Clarke PM; Robinson LJ; Laman M; Davis TME
    Malar J; 2017 Oct; 16(1):438. PubMed ID: 29084540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness study of three antimalarial drug combinations in Tanzania.
    Wiseman V; Kim M; Mutabingwa TK; Whitty CJ
    PLoS Med; 2006 Oct; 3(10):e373. PubMed ID: 17032059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.
    Lussiana C; Floridia M; Martinho do Rosário J; Fortes F; Allan R
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):588-596. PubMed ID: 27856948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic costs of malaria in four Kenyan districts: do household costs differ by disease endemicity?
    Chuma J; Okungu V; Molyneux C
    Malar J; 2010 Jun; 9():149. PubMed ID: 20515508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
    Mori AT; Norheim OF; Robberstad B
    Pharmacoeconomics; 2016 Mar; 34(3):303-14. PubMed ID: 26521172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health. From financing to fevers: lessons of an antimalarial subsidy program.
    Laxminarayan R; Arrow K; Jamison D; Bloom BR
    Science; 2012 Nov; 338(6107):615-6. PubMed ID: 23118173
    [No Abstract]   [Full Text] [Related]  

  • 16. Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.
    Staedke SG; Mwebaza N; Kamya MR; Clark TD; Dorsey G; Rosenthal PJ; Whitty CJ
    Lancet; 2009 May; 373(9675):1623-31. PubMed ID: 19362361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
    Zurovac D; Njogu J; Akhwale W; Hamer DH; Snow RW
    Trop Med Int Health; 2008 Jan; 13(1):99-107. PubMed ID: 18291008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?
    Rolland E; Checchi F; Pinoges L; Balkan S; Guthmann JP; Guerin PJ
    Trop Med Int Health; 2006 Apr; 11(4):398-408. PubMed ID: 16553923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework.
    Mori AT; Kaale EA
    Implement Sci; 2012 Mar; 7():18. PubMed ID: 22423610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.
    Prudhomme O'Meara W; Menya D; Laktabai J; Platt A; Saran I; Maffioli E; Kipkoech J; Mohanan M; Turner EL
    PLoS Med; 2018 Jul; 15(7):e1002607. PubMed ID: 30016316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.